Diffusion-Weighted MRI Technique Cuts Breast Biopsy Requirements
|
By MedImaging International staff writers Posted on 18 Oct 2015 |

Image: A diagnostic DWIBS MRI mammography demonstrating a lesion (Photo courtesy of DKFZ).
An abbreviated magnetic resonance imaging (MRI) protocol could reduce unnecessary breast biopsies by providing additional information on suspicious X-ray screening mammography findings, according to a new study.
Researchers at the German Cancer Research Center (DKFZ; Heidelberg, Germany), University Hospital Heidelberg (Germany), and other institutions conducted a study to evaluate the ability of an abbreviated MRI protocol consisting of maximum intensity projections (MIPs) from diffusion-weighted imaging with background suppression (DWIBS) and unenhanced morphologic sequences to help predict the likelihood of malignancy on suspicious screening X-ray mammograms, as compared with an abbreviated contrast material-enhanced MRI protocol and a full diagnostic breast MRI protocol.
To do so, 50 women (mean age 57.1 years), who gave informed consent and who had suspicious screening mammograms and an indication for biopsy participated in a prospective study from September 2014 to January 2015. Before biopsy, a full diagnostic contrast-enhanced MRI was performed that included DWIBS. Two abbreviated protocols based on MIPs were evaluated; the first showed the shape and appearance of the lesion; the second displayed its biophysiological properties with DWIBS, a technique that works by assessing the diffusion of water molecules through tissue, since areas of restricted diffusion may indicate malignancy.
The results showed that 25 of the 50 participants had a breast carcinoma. DWIBS achieved a comparable accuracy to that of the full diagnostic and the abbreviated contrast-enhanced MRI protocols, yielding an excellent negative predictive value of 92%. Only pure microcalcification related ductal carcinoma in-situ (DCIS) without solid tumor—a very early stage of breast cancer—was not detected by any of the MRI techniques. The study was published early online on September 11, 2015, in Radiology.
“If the preliminary findings are confirmed, this approach could have a high potential to be used as an adjunct in the clarification process of unclear lesions on X-ray mammography in breast cancer screening,” said lead author Sebastian Bickelhaupt, MD, a radiologist at DKFZ. “This might help to reduce the number of invasive biopsies and the related anxiety in women who have suspicious findings at mammography.”
DWIBS MRI holds several advantages; the images can be obtained in less than seven minutes, compared with more than 30 minutes for a full breast MRI protocol; and the mean reading time using the unenhanced DWIBS method is less than 30 seconds thanks to MIPS, a technique that allows lesion assessment by reading one summation image instead of multiple single-slice images. The technique however, is in its early stages, and as such is not intended as a standalone screening modality but as an adjunct to X-ray mammography and tomosynthesis.
Related Links:
German Cancer Research Center
University Hospital Heidelberg
Researchers at the German Cancer Research Center (DKFZ; Heidelberg, Germany), University Hospital Heidelberg (Germany), and other institutions conducted a study to evaluate the ability of an abbreviated MRI protocol consisting of maximum intensity projections (MIPs) from diffusion-weighted imaging with background suppression (DWIBS) and unenhanced morphologic sequences to help predict the likelihood of malignancy on suspicious screening X-ray mammograms, as compared with an abbreviated contrast material-enhanced MRI protocol and a full diagnostic breast MRI protocol.
To do so, 50 women (mean age 57.1 years), who gave informed consent and who had suspicious screening mammograms and an indication for biopsy participated in a prospective study from September 2014 to January 2015. Before biopsy, a full diagnostic contrast-enhanced MRI was performed that included DWIBS. Two abbreviated protocols based on MIPs were evaluated; the first showed the shape and appearance of the lesion; the second displayed its biophysiological properties with DWIBS, a technique that works by assessing the diffusion of water molecules through tissue, since areas of restricted diffusion may indicate malignancy.
The results showed that 25 of the 50 participants had a breast carcinoma. DWIBS achieved a comparable accuracy to that of the full diagnostic and the abbreviated contrast-enhanced MRI protocols, yielding an excellent negative predictive value of 92%. Only pure microcalcification related ductal carcinoma in-situ (DCIS) without solid tumor—a very early stage of breast cancer—was not detected by any of the MRI techniques. The study was published early online on September 11, 2015, in Radiology.
“If the preliminary findings are confirmed, this approach could have a high potential to be used as an adjunct in the clarification process of unclear lesions on X-ray mammography in breast cancer screening,” said lead author Sebastian Bickelhaupt, MD, a radiologist at DKFZ. “This might help to reduce the number of invasive biopsies and the related anxiety in women who have suspicious findings at mammography.”
DWIBS MRI holds several advantages; the images can be obtained in less than seven minutes, compared with more than 30 minutes for a full breast MRI protocol; and the mean reading time using the unenhanced DWIBS method is less than 30 seconds thanks to MIPS, a technique that allows lesion assessment by reading one summation image instead of multiple single-slice images. The technique however, is in its early stages, and as such is not intended as a standalone screening modality but as an adjunct to X-ray mammography and tomosynthesis.
Related Links:
German Cancer Research Center
University Hospital Heidelberg
Latest MRI News
- Cardiac MRI Detects Hidden Heart Dysfunction After Heart Attack
- AI Tool Reveals Cortical Lesions on Standard MRI in Multiple Sclerosis
- AI Reconstruction Tool Speeds Dynamic Breast MRI and Improves Cancer Detection
- International Study Assesses AI for Prostate Cancer MRI Interpretation
- AI Approach Could Shorten Advanced Brain MRI Scans by Up to 90%
- Cardiac MRI Measure Improves Risk Prediction in Tricuspid Regurgitation
- AI System Improves Accuracy of Cardiac MRI Interpretation
- Deep Learning Model Predicts Alzheimer’s Disease Outcomes from Baseline MRI
- Blood-Brain Barrier Imaging Adds Risk Insight to Standard Stroke MRI
- AI Body Composition MRI Analysis Predicts Cardiometabolic Disease Risk
- AI MRI Tool Quantifies Muscle Fat to Assess Cardiometabolic Risk
- Advanced MRI Visualizes CSF Motion Changes After Mild Traumatic Brain Injury
- MRI Tool Enables Long-Term Tracking of Transplanted Cardiac Cells
- MRI-Based AI Tool Supports Differentiation of Parkinsonian Syndromes
- MRI-Derived Biomarker Improves Risk Stratification in Glioblastoma
- Combined Imaging Approach Identifies Cause of Heart Attack without Coronary Blockage
Channels
Radiography
view channel
AI Tool Predicts Five-Year Breast Cancer Risk from Mammograms
Breast cancer risk assessment during routine screening is difficult because many women who develop the disease have no known genetic mutations or family history. Static risk tools provide limited discrimination... Read more
AI Mammography Tools Detect Early Breast Cancer Signs Years Before Diagnosis
Breast cancer screening aims to detect tumors before symptoms develop, but subtle mammographic changes can appear years before diagnosis and may be missed during routine reads. Delayed detection can lead... Read moreUltrasound
view channel
Simple 2D Ultrasound Tool Accurately Estimates Placental Volume
Stillbirth remains a major cause of perinatal loss, with about 21,000 cases annually in the United States. Although placental abnormalities are linked to adverse pregnancy outcomes, routine monitoring... Read more
Portable 3D Ultrasound System Enables Reproducible Breast Cancer Monitoring
Breast cancer can develop between annual mammograms, and these interval cancers account for 20% to 30% of cases and tend to be more aggressive. The challenge is pronounced in people with dense breast tissue.... Read moreNuclear Medicine
view channel
Radiotherapy Professionals Embrace AI as a Clinical Support Tool
Radiotherapy planning requires precise identification of organs at risk near a tumor, but manual contouring is repetitive and time-consuming, often delaying plan completion and straining specialist capacity.... Read more
Second PSMA PET Identifies Disease in More Than Half of Negative Cases
Biochemical recurrence of prostate cancer after prostatectomy or radiation can be difficult to localize when imaging is negative. Uncertain disease sites may delay salvage therapy and expose patients to... Read moreGeneral/Advanced Imaging
view channel
Virtual Staining Technique Creates Histology Images from CT Data
Pulmonary hypertension, a disorder marked by pathological remodeling of the pulmonary vessels, often requires detailed histologic assessment. Yet routine pathology remains anchored in labor‑intensive,... Read more
CT-Derived Biomarker Predicts Outcomes in Gastric Cancer
Gastric cancer, also known as stomach cancer, is the fifth most common malignancy worldwide and often shows heterogeneous outcomes even within the same stage. Prognostic estimates typically rely on tumor-centric... Read more
AI Tool Enhances Response Assessment and Survival Prediction in Pleural Mesothelioma
Pleural mesothelioma, a cancer that grows as a thin, irregular layer along the lung wall, is difficult to measure on imaging. Clinicians rely on diameter-based Response Evaluation Criteria in Solid Tumors... Read moreImaging IT
view channel
Ambient AI Reporting Platform Streamlines Radiology Reporting
Radiology departments face growing imaging volumes and staffing shortages, creating reporting bottlenecks and pressure to maintain turnaround times. Conventional dictation tools document findings after... Read more
Interactive AI Tool Supports Explainable Lung Nodule Assessment
Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read moreIndustry News
view channel
GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026
Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare is highlighting Intelligent Radiation Therapy (iRT), MIM Software innovations, and BK Medical surgical... Read more







